Human immunodeficiency virus-associated lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Year: 2024
Type: article
Abstract: Non-Hodgkin lymphoma (NHL) remains the most common type of cancer and a leading cause of mortality in people who are living with human immunodeficiency virus (HIV).1 This is despite a marked decrease in the incidence of HIV-associated NHL (HIV–NHL) following the introduction of combination antiretroviral therapy (ART) in the mid-1990s.2 In contrast, the incidence of Hodgkin lymphoma (HL) increased slightly but has remained stable since 2000.1 Compared with the age- and gender-matched general population, the incidences of HIV–NHL and HIV-associated HL (HIV–HL) are increased ∼10- to 20-fold.
Source: Annals of Oncology
Authors: K. Hübel, M. Bower, I. Aurer, M. Bastos-Oreiro, C. Besson, U. Brunnberg, C. Cattaneo, S. Collins, K. Cwynarski, A. Dalla Pria, M. Hentrich, C. Hoffmann, M.J. Kersten, S. Montoto, J.T. Navarro, E. Oksenhendler, A. Re, J.-M. Ribera, P. Schommers, B. von Tresckow, C. Buske, M. Dreyling, A. Davies
Institutions: University of Cologne, University Hospital Cologne, Chelsea and Westminster Hospital, University Hospital Centre Zagreb, University of Zagreb, Hospital General Universitario Gregorio Marañón, Inserm, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Centre de recherche en Epidémiologie et Santé des Populations, Centre Hospitalier de Versailles, Goethe University Frankfurt, University Hospital Frankfurt, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University College Hospital, Ludwig-Maximilians-Universität München, Infektionsmedizinisches Centrum Hamburg, Amsterdam University Medical Centers, Cancer Center Amsterdam, St Bartholomew's Hospital, Barts Health NHS Trust, Universitat Autònoma de Barcelona, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia, Hôpital Saint-Louis, Essen University Hospital, University of Duisburg-Essen, Universität Ulm, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,600
OpenAlex ID: W4402172252